Maria-Luisa Maccecchini's Net Worth

$7.13 Million

Estimate Recalculated Sep 8, 2024 07:20PM EST

Who is Maria-Luisa Maccecchini?

Maria-Luisa Maccecchini has an estimated net worth of $7.13 Million. This is based on reported shares across multiple companies, which include COMPETITIVE TECHNOLOGIES INC, Annovis Bio, Inc., and Lantern Pharma Inc..

SEC CIK

Maria-Luisa Maccecchini's CIK is 0001315018

Past Insider Trading and Trends

2023 was Maria-Luisa Maccecchini's most active year for acquiring shares with 7 total transactions. Maria-Luisa Maccecchini's most active month to acquire stocks was the month of December. 2024 was Maria-Luisa Maccecchini's most active year for disposing of shares, totalling 3 transactions. Maria-Luisa Maccecchini's most active month to dispose stocks was the month of December. 2021 saw Maria-Luisa Maccecchini paying a total of $496,980.00 for 318,000 shares, this is the most they've acquired in one year. In 2020 Maria-Luisa Maccecchini cashed out on 1,079,165 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

COMPETITIVE TECHNOLOGIES INC No price found

Investor

Maria-Luisa Maccecchini owns 2,500 units of Common Stock. In the year 2005 Maria-Luisa Maccecchini acquired a total of 2,500 shares in COMPETITIVE TECHNOLOGIES INC.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
2.5K
—
—
2.5K
Jan 3 - Jan 4
Form 4/A
—
0
—
—
0
Jan 14
Form 3
—
0
—
—
0
No matching records found

Annovis Bio, Inc. (ANVS) Snapshot price: $7.8591

President and CEO

Maria-Luisa Maccecchini owns 1,068,459 units of Common Stock which is worth $8,397,126.13. From 2020 to 2024 Maria-Luisa Maccecchini acquired a total of 978,303 shares in Annovis Bio, Inc. at a cost of $1,270,695.98, Maria-Luisa also disposed a total of 33,000 shares of Annovis Bio, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.73%
-30.00K
—
—
1.07M
Nov 17 - Mar 31
Form 4/A
+3.87%
40.97K
$6.10
$249,917.00
1.1M
Nov 20
Form 4
+3.89%
41.19K
$6.07
$249,999.02
1.1M
Nov 20
Form 4
-0.28%
-3.00K
—
—
1.06M
Apr 24
Form 4
+1.92%
20K
$12.61
$252,200.00
1.06M
Apr 7
Form 4
+5.34%
52.76K
$0.14
$7,385.70
1.04M
Feb 6
Form 4
—
0
—
—
0
Jan 18
Form 4
+3.45%
32.96K
$0.14
$4,614.26
987.73K
Jan 14
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Dec 6
Form 4
+1.88%
18K
$27.61
$496,980.00
976.77K
Oct 11
Form 4
—
0
—
—
0
Jul 7
Form 4
—
0
—
—
0
Apr 9
Form 4
+374.35%
772.43K
$6.00
—
978.77K
Jan 31
Form 3
—
0
—
—
0
No matching records found

Lantern Pharma Inc. (LTRN) Snapshot price: $3.65

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
Oct 20
Form 3
—
0
—
—
0
No matching records found